Amarin Corp Plc (AMRN)

[alm2]

BO crazy talk
If Amarin is to be BO it will not be until after appeal-why?
1covid will have knocked V’s sales trajectory in 2020-the patent case loss will have no possible impact until well after appeal
2-if-amarin wins it will be back on track as to sales - maybe a lost year in terms of sales pushing through 2020-but would have been dented by covid anyway
3 if win appeal BO by pharma will be valued at perhaps one years less sales but hopefully markets generally will be recovering from covid by then
4 if loss - then can get what they can from EU and Row and whatever may be fought over with generics as to USA
5whats the upside benefit of selling now - monkey nuts -as to BO value of USA- value EU and Row remain essentially same now and in April 2021
6 what’s the upside selling after appeal win -huge
7 what are chances of win -way more than 50 -50-so why risk huge possible benefit from win against a money nut sale now
8 the company will not be bought out until post appeal - Jt would not be looking after shareholders interests by doing so - someone can try do the comparative guess value maths on this but it’s a no brainer
9 amararin can easily survive this year and next - they will cut costs / sales force / advertising- money poorly spent in a covid affected year
10 they can afford to sit and wait and deliver on appeal
11 longs who sit through to successful appeal will be very happy 6 dollars now - what price post an appeal win
12 upside is great - downside is low
Alm